[{"id":"9e066b71-7f4b-4632-8ecf-e6e2e35a7dd0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05427487","created_at":"2022-06-22T21:54:15.197Z","updated_at":"2025-02-25T14:08:55.980Z","phase":"Phase 1","brief_title":"Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours","source_id_and_acronym":"NCT05427487","lead_sponsor":"ImmVirx Pty Ltd","biomarkers":" MSI","pipe":"","alterations":" ","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tyvyt (sintilimab) • IVX037"],"overall_status":"Recruiting","enrollment":" Enrollment 70","initiation":"Initiation: 02/17/2023","start_date":" 02/17/2023","primary_txt":" Primary completion: 09/30/2026","primary_completion_date":" 09/30/2026","study_txt":" Completion: 11/30/2026","study_completion_date":" 11/30/2026","last_update_posted":"2025-02-17"}]